Viewing Study NCT05717166


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-01-02 @ 4:54 AM
Study NCT ID: NCT05717166
Status: RECRUITING
Last Update Posted: 2025-04-29
First Post: 2023-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Sponsor: David Palma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module